Home/Filings/4/0001437749-22-007741
4//SEC Filing

Cummings James F. 4

Accession 0001437749-22-007741

CIK 0000072444other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 9:24 PM ET

Size

15.2 KB

Accession

0001437749-22-007741

Insider Transaction Report

Form 4
Period: 2022-03-28
Cummings James F.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-03-28+43,75043,750 total
  • Award

    Stock Option (right to buy)

    2022-03-28+262,500262,500 total
    Exercise: $5.09Exp: 2032-03-27Common Stock (262,500 underlying)
Footnotes (2)
  • [F1]Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the fourth anniversary of the grant date.
  • [F2]The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 28, 2023, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 28, 2026.

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001886760

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 9:24 PM ET
Size
15.2 KB